CANY
IGMS

Caxton Associates (New York)’s IGM Biosciences IGMS Stock Holding History

Caxton Associates (New York)’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,009
Closed -$343K – 552
2022
Q2 		$343K Buy
+19,009
New +$343K 0.03% 328